Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05102565 · ClinicalTrials.gov registry record · NA

A Dyadic Telehealth Program for Alzheimer's Patients/Caregivers

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
29
Enrollment target

NCT05102565: Completed NA study, sponsored by University of California, Los Angeles.

NCT05102565 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05102565, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

This study aims to refine and evaluate feasibility of a telehealth intervention for persons with Alzheimer's disease and their caregivers. The intervention will use evidence-based techniques for decreasing symptoms of depression, anxiety, and poor sleep, that are commonly reported among this vulnerable group during the COVID-19 pandemic. Improved symptoms among this group may improve their other health outcomes and quality of life and furthermore the quality of care that caregivers provide for persons with Alzheimer's disease during this challenging time.

Primary Outcome

Nighttime sleep efficiency (i.e., mean percent of time in bed spent asleep) will be calculated from 7 days of wrist actigraphy for patients and caregivers. Range from 0 to 100% with a higher percent indicating better objective sleep quality

Interventions

  • BEHAVIORAL sleep education program

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2021-09-28
Est. Completion 2023-06-30
Phase NA

What the finished NCT05102565 record still lists

NCT05102565 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which sleep education program is the first listed.

NCT05102565 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05102565 about?

NCT05102565 is a clinical study titled "A Dyadic Telehealth Program for Alzheimer's Patients/Caregivers". This study aims to refine and evaluate feasibility of a telehealth intervention for persons with Alzheimer's disease and their caregivers. The intervention will use evidence-based techniques for decreasing symptoms of depression, anxiety, and poor sleep, that are commonly reported among this vulnera...

What is the current status of trial NCT05102565?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2021-09-28. Estimated completion is 2023-06-30.

What interventions are being tested in trial NCT05102565?

The interventions under investigation include: sleep education program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05102565?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05102565's enrollment target sits among peer trials

29 1702nd of 2000 higher than 297 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05102565, the US trial registry maintained by the National Library of Medicine. NCT05102565 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.